[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"footer-data":3,"$fWQApNJTG9DLLl9dvPZELZpR9uy2zKhKfX_gswfj7fe0":13},{"email":4,"socmed":5,"footer_tagline":6,"location":7},"inquiries@lontarhealth.com",[],"Global Expertise,  Local Health Impact",[8,11],{"name":9,"link":10},"Jakarta",null,{"name":12,"link":10},"Singapore",{"id":14,"title":15,"slug":16,"published_date":17,"topic":18,"regions":21,"image":22,"thumbnail_image_courtesy":23,"description":24,"writer_name":25,"writer_information":26,"writer_bio_link":27,"writer_image":28,"related_services":29,"insight_notes":72,"highlighted":73,"seo":74},11,"Mister Minister of Health; let us collaborate to fix healthcare costs today!","mister-minister-of-health-let-us-collaborate-to-fix-healthcare-costs-today","2025-02-12",{"id":19,"topic_name":20},4,"Partnerships & Development",[],"https:\u002F\u002Fassets.lontarhealth.com\u002Fstorage\u002Ffiles\u002Flet-us-collaborate-to-fix-healthcare-costs-today.jpg","(Courtesy Antara\u002FSulthony Hasanuddin)","\u003Cp>Minister of Health Budi Gunadi Sadikin recently highlighted the \u003Cstrong>rapid rise in healthcare costs\u003C\u002Fstrong> in Indonesia, with national health spending growing at a faster rate compared to GDP. He warned that the healthcare system would not be sustainable if solutions to create \u003Cstrong>more transparency\u003C\u002Fstrong> \u003Cstrong>in costs\u003C\u002Fstrong> are not implemented.\u003C\u002Fp>\r\n\r\n\u003Cp>His renewed claim that drug prices are "300% to 400% higher than Malaysia" raises the same questions. Why would the innovative pharmaceutical industry introduce innovation in a market hegemonized by generics (80% share) only to make it inaccessible?\u003C\u002Fp>\r\n\r\n\u003Cp>For International Pharmaceutical Manufacturers Group (IPMG) , innovation in pharmaceuticals, is critical—it saves lives, improves quality of care, and drives progress. But what’s the value of an innovative drug or treatment if it’s not accessible to those who need it the most? As an industry, we invest in research, development, and breakthroughs. However, innovation becomes meaningless if it's priced out of reach for eligible patients due to lack of transparency, inefficiencies, lack of reimbursement or regulatory bottlenecks. True innovation is only impactful when it is accessible and affordable, ensuring that patients—especially those in need—can benefit from it.\u003C\u002Fp>\r\n\r\n\u003Cp>At International Pharmaceutical Manufacturers Group (IPMG) , we believe that the debate over drug prices needs to be grounded in comprehensive research, not just anecdotal cases. We call for a \u003Cstrong>value-based approach to healthcare\u003C\u002Fstrong> and a focus on the interventions that deliver the \u003Cstrong>most effective\u003C\u002Fstrong>, \u003Cstrong>efficient and sustainable outcomes\u003C\u002Fstrong>.\u003C\u002Fp>\r\n\r\n\u003Cp>The recently launched \u003Cstrong>IPMG Manifesto\u003C\u002Fstrong> advocates for a comprehensive pharmaceutical strategy to enhance Indonesia's healthcare system and catalyze economic growth. Time for action is now. Let us to make the case for supporting a shift towards affordable and quality healthcare for all.\u003C\u002Fp>\r\n\r\n\u003Cp> \u003C\u002Fp>\r\n\r\n\u003Cp>#Indonesia #UHC #AffordableHealthcare #InnovationForAll #ValueBasedHealthcare #CollaborationForChange #IPMGManifesto\u003C\u002Fp>","Ait-Allah Mejri","Ait-Allah is a healthcare leader with nearly four decades of experience.","https:\u002F\u002Fwww.lontarhealth.com\u002Four-founders","https:\u002F\u002Fassets.lontarhealth.com\u002Fstorage\u002Ffiles\u002Fwriter-ait-allah-mejri.png",[30,51],{"id":31,"title":32,"image":33,"icon":34,"tagline":35,"brief_description":36,"we_deliver":37,"end_product_description":50},2,"Policy Strategy for Access & Reimbursement","https:\u002F\u002Fassets.lontarhealth.com\u002Fstorage\u002Ffiles\u002Fservice-policy-strategy-for-access-reimbursement-bg.png","https:\u002F\u002Fassets.lontarhealth.com\u002Fstorage\u002Ffiles\u002Fservice-policy-strategy-for-access-reimbursement-icon.png","Where innovation meets affordability.","\u003Cp>We support client in shaping access frameworks, reimbursement pathways, and pricing strategies that balance commercial value with public health impact.\u003C\u002Fp>",[38,40,42,44,46,48],{"text":39},"Access and reimbursement strategy aligned with policy priorities.",{"text":41},"Non-HTA value framing and narrative development.",{"text":43},"Stakeholder and payer engagement strategy.",{"text":45},"Formulary inclusion navigation and process mapping.",{"text":47},"Evidence framing for policy discussions.",{"text":49},"Policy opportunity analysis and advocacy positioning.","\u003Cul>\r\n\t\u003Cli>Access & reimbursement strategy\u003C\u002Fli>\r\n\t\u003Cli>Policy engagement plan\u003C\u002Fli>\r\n\t\u003Cli>Formulary Inclusion Roadmap\u003C\u002Fli>\r\n\t\u003Cli>Value & Evidence Messaging Guide\u003C\u002Fli>\r\n\t\u003Cli>Public-Private Access Proposal\u003C\u002Fli>\r\n\u003C\u002Ful>",{"id":52,"title":53,"image":54,"icon":55,"tagline":56,"brief_description":57,"we_deliver":58,"end_product_description":71},3,"Public‒Private Partnerships & Innovative Financing","https:\u002F\u002Fassets.lontarhealth.com\u002Fstorage\u002Ffiles\u002Fservice-ppp-innovative-financing-bg.png","https:\u002F\u002Fassets.lontarhealth.com\u002Fstorage\u002Ffiles\u002Fservice-ppp-innovative-financing-icon.png","From pilot to lasting impact","\u003Cp>We design and manage partnerships that turn proven concepts into scalable programs, ensuring sustainability through local ownership and system alignment.\u003C\u002Fp>",[59,61,63,65,67,69],{"text":60},"Partnership design, governance, and sustainability planning.",{"text":62},"Stakeholder alignment across government, NGOs, donors, and industry.",{"text":64},"Feasibility and readiness assessment for PPP models.",{"text":66},"Light-touch financing options analysis.",{"text":68},"Concept development for donor or government submission.",{"text":70},"Scalability and institutionalization planning.","\u003Cul>\r\n\t\u003Cli>PPP Concept Notes\u003C\u002Fli>\r\n\t\u003Cli>Partnership Roadmap\u003C\u002Fli>\r\n\t\u003Cli>Stakeholder Alignment Map\u003C\u002Fli>\r\n\t\u003Cli>Financing Options Brief\u003C\u002Fli>\r\n\t\u003Cli>Implementation & Governance Framework\u003C\u002Fli>\r\n\t\u003Cli>Transition to Scale Plan\u003C\u002Fli>\r\n\u003C\u002Ful>","At Lontar Health Partners, we translate policy and market insight into strategies that deliver measurable access and system change.",true,{"meta_title":10,"meta_description":10,"meta_keywords":10,"og_image":10}]